Objective: Information about the incidence of neonatal seizures (NS) is scarce.
1 | INTRODUCTION
| Background
During the neonatal period, neurologic diseases manifest themselves mostly with seizures 1 that are often related to an unfavorable outcome, such as death, cerebral palsy, intellectual disability, and epilepsy. 2 Currently, the epidemiology of neonatal seizures (NS) is not well defined. The frequency of NS has been calculated both in population-based and clinic-based studies, the majority of which are based on a clinical diagnosis of seizures. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] However, the clinical evaluation alone is unreliable and can lead to misdiagnosis and, consequently, to inappropriate treatment. 17 Polygraphic video-electroencephalography (v-EEG) monitoring should always be performed to understand if the paroxysmal movement is epileptic in origin, and it is the only way to identify electrical-only seizures in high-risk infants. Information about the incidence of NS is scarce, particularly in Europe. We found only one accessible European study, an old one performed in the Stockholm area, which focused exclusively on full-term infants with clinically identified seizures. 4 In that study, the incidence of NS was 1.5 per 1000 full-term deliveries.
| Objective
The aim of this population-based study was to calculate the incidence of EEG-confirmed NS during a period of 13 years (2002-2014) in infants born in the province of Parma, a geographic area situated in the Emilia-Romagna region of Italy. In this area, all the cases with suspected NS or thought to be at high risk of NS were systematically evaluated with v-EEG recordings in the same center. All survivors were followed up clinically, and perinatal risk factors for mortality and epilepsy after NS were evaluated.
| MATERIALS AND METHODS
This study was performed at the neonatal intensive care unit (NICU) of the Parma University Hospital, a tertiary level facility in the Emilia-Romagna region. This NICU is the NS referral center for the entire province of Parma (448 207 inhabitants; www.provincia.parma.it) and collects all neonates with suspected NS or those with conditions putting them at high risk for seizures from all the obstetricneonatology units of this area (Parma University Hospital, Fidenza Hospital, Borgo Val di Taro Hospital, and Casa di Cura Città di Parma Hospital). Infants born outside the province and transferred to the NICU for neonatal care were excluded. We reviewed the reasons for EEG requests in all neonates born in the province of Parma with at least a v-EEG recording performed between January 2002 and December 2014. Among them, we identified the patients who presented EEG-confirmed seizures. EEG studies were analyzed by a clinical neurophysiologist (FP) as part of clinical practice, and then, for the purpose of this study, they were reviewed by a senior pediatric neurologist (BP) with expertise in reading neonatal EEG recordings. All seizures were identified and noted independently by the 2 electroencephalographers, and where disagreements were found, the experts had a discussion to reach a consensus. NS were clinically defined according to Volpe's classification, modified by Lombroso, as subtle, focal clonic, multifocal clonic, focal tonic, generalized tonic, and myoclonic. 1 As suggested by the International League Against Epilepsy (ILAE), spasms were added as a type of seizure, and electrographic changes had to be associated with clinical events to define a neonatal seizure. 18 In line with others, 19, 20 ictal EEG discharges, sometimes representing electrical-only seizures, were characterized by an abnormal, evolving pattern with a minimum 2 μV amplitude and duration of at least 10 seconds. Polygraphic EEG recordings were obtained with a Micromed 21-channel synchronized digital v-EEG system at the bedside in the NICU; 21 or 10 cerebral electrodes, depending on the infant's head size, were applied according to the 10-20 International System; extracerebral leads were applied for respiratory and electrocardiogram recording and for surface electromyography. Only the recordings with the first NS were considered, and they included a complete cycle of awake, quiet, and active sleep states or, whenever state changes were not clearly distinguishable, they lasted a minimum of 60 minutes. A bedside observer was always present during the recording, in order to press an event marker, enter information directly into the digital file, and alert the clinical neurophysiologist to clinically important events. Patients' data (sex, gestational age at birth, type of delivery, birth weight, Apgar score, medical
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• Information about the incidence of neonatal seizures is scarce • Previous population-based and clinic-based studies about the incidence of neonatal seizures relied mostly on a clinical diagnosis • This population-based, retrospective study evaluates the incidence of EEG-confirmed seizures in neonates born in the province of Parma between January 2002 and December 2014 • Perinatal risk factors for mortality and epilepsy after neonatal seizures were also analyzed diseases and conditions, and reasons for EEG request) were obtained from the history collected at the time of the EEG recording and from the hospital charts. The study was approved by the institutional review board of Parma University. In accordance with the current practice at our institution, a consent form was signed by the parents of patients to approve the use of patient's information or material for scientific purposes, and informed consent was placed in the patient's hospital chart.
| RESULTS
In the 13-year period of this study, 476 neonates (273 preterm and 203 term) born in the province of Parma were recorded with at least a v-EEG for suspected NS or for medical conditions presenting a seizure risk, such as birth asphyxia, brain malformations, sepsis, meningitis, intraventricular hemorrhage, metabolic disorders, 21 10.78-17.79). Incidence was inversely correlated to gestational age: 5.01/1000 for infants born between 31 and 36 weeks of gestation, 54.9/1.000 for those born between 28 and 30 weeks of gestation, and 85.6/1000 for <28 weeks of gestation. An increasing risk was also associated with decreasing birth weight: 1.19/1000 for infants weighing 2500 g or more, 4.8/1000 between 1500 and 2499 g, 34.03/1000 between 1000 and 1499 g, and 127.57/ 1000 in infants born <1000 g. The group of extremely preterm newborns (<28 weeks of gestation) showed a later seizure onset compared to the other preterm infants (14.48 days vs 7 days).
Among 112 patients with NS, 28 (25%) died after a median time of 19 days (min 0 days, max 3 years and 9 months), 16 (14.3%) had a diagnosis of epilepsy, 33 (29.5%) had cerebral palsy, and 39 (34.8%) had a developmental delay. The majority of patients (20/28, 71 .4%) died during the neonatal period, 7 preterm neonates died within 6 months of life (25%), and only one patient, affected by nonketotic hyperglycinemia, died later when he was 3 years and 9 months old (3.5%). Among the 6 term neonates who died, the etiology was HIE in 3 (50%), inborn errors of metabolism in 2 (33.3%), and infection in one (16.6%), whereas among the preterm neonates, the etiology was brain hemorrhage in 12 (54.5%), HIE in 7 (31.8%), infection in 2 (9%), and cerebral malformation in one (4.5%). Results of univariate analysis of risk factors for mortality after NS are shown in Table 2 . Gestational age, birth weight, 5-minute Apgar score, etiology, ultrasound brain scan, EEG background activity, and neurologic examination were significant in univariate models and were included in the multivariate model. Only the 5-minute Apgar score (P = 0.0062) and etiology (P = 0.0195) retained significance in the multivariate analysis. Mortality increased in neonates with the lowest 5-minute Apgar scores: compared to neonates with a score of 8-10, those with a score of 0-3 had an adjusted hazard ratio (HR) of 59.7 (95% CI 7.0-509.6), whereas those with a score of 4-7 had an adjusted HR of 10. Table 3 . Only gender, EEG background activity, and the presence of status epilepticus were significant in univariate models. In the multivariate analysis, gender and status epilepticus retained significance: females (adjusted HR 5.8, 95% CI 1.8-19.4, P = 0.0043) and neonates with status epilepticus (adjusted HR 6.6, 95% CI 1.9-22.8, P = 0.0030) showed a higher risk of epilepsy.
| DISCUSSION
This population-based study evaluated the incidence of EEG-confirmed NS between 2002 and 2014 in the province of Parma. The presence of only one tertiary referral center for neonatal care in the study area where, according to standard procedures, all newborns with suspected seizures or with a medical condition at risk for seizures are referred from all obstetric-neonatology units of the province, allows us to obtain an accurate evaluation of the incidence of NS in infants born in the study area. Furthermore, for the entire period of the study, all v-EEGs were interpreted and confirmed by experts in neonatal EEG. We chose to consider only EEG-confirmed NS, as suggested by the ILAE, because clinical evaluation alone is not reliable and could lead to false-positive diagnoses. This is confirmed by the fact that in only 74/205 patients recorded for "paroxysmal events/suspected NS," the v-EEG showed ictal changes. If we had made a clinical diagnosis without EEG confirmation in these 205 patients, we might have overestimated the incidence of NS in our sample. The risk of overestimation of NS is an important limitation of the studies based only on a clinical approach.
2,3,5-7,10-16 Moreover, a clinical approach does not allow the identification of electrical-only seizures that are quite frequent in newborns at risk, leading to underdiagnosis of the disease. In our sample, 112 patients presented EEG-confirmed NS, and most of them had electroclinical seizures (102 newborns; 46 fullterm, 56 preterm), sometimes associated with electrical seizures (10 full-term, 4 preterm), whereas 10 had only electrical seizures (10 full-term, 4 preterm).
We found an overall incidence of NS of 2.29/1000 live births (2.09/1000 when only electroclinical seizures were considered) with higher rates in preterm than in full-term newborns. Other population-based studies have reported incidence rates higher than ours (Table 4) . In a retrospective cohort study on neonates born to residents of Fayette County, Kentucky, USA, 58 cases were identified, giving a crude rate of 3.5 per 1000 live births. 22 In that study, however, NS were identified through clinical details or an EEG record. In addition, 15 neonates had possible seizures (the clinical episode had no EEG correlate, the description of the seizure was inadequate, an alternative diagnosis was equally possible, or the treating physician considered the episode only a possible seizure). In a US nationwide study based on International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes in hospital charts, an incidence of 2.84 per 1000 live births was found. 23 In that study, the validity of the ICD codes was not tested and the possibility exists that several nonepileptic episodes were misdiagnosed as NS. The presence of paroxysmal generalized and/or focal movements was required in a study done in Newfoundland, Canada, which provided an incidence of 2.6 per 1000 live births. 8 However, the study did not require EEG seizure equivalents. The only European study investigated NS in full-term infants and provided an incidence of 1.5 per 1000 live births (compared to 1.1 per 1000 in our study). 4 However, the authors did not specify the criteria used for the diagnosis. Two other population-based studies found incidence rates lower than ours. In a study done in Harris County, Texas, USA, 9 207 neonates were identified, giving an incidence of 1.8 per 1000 live births. In that study, NS were identified through clinical assessment. The concurrent EEG documentation, performed in 95% of cases (197/207), However, as confirmed by the authors, the accuracy of coding for seizures was unknown. As compared to these reports, we can conclude that the incidence of NS, as calculated in our study, is perhaps the most realistic estimate of this clinical condition. In contrast to population-based studies, clinic-based studies tend to present a higher incidence of NS because the infants considered are affected by central nervous system injuries that would predispose them to seizures. 2, 3, [5] [6] [7] [10] [11] [12] [13] [14] 16, 25 Furthermore, not all studies include premature infants but, when they are considered, a higher incidence of seizures is reported for preterm neonates [7] [8] [9] [10] [11] [12] 25 and for infants with low birth weight, 8, 9, 11, 22, 23 as in the present study. In our sample, the incidence of NS increased with decreasing gestational age at birth and with decreasing birth weight. These findings are in keeping with several others 8, 9, [22] [23] [24] 26 and confirm the increased risk of seizures in preterm infants. Indeed, preterm birth is at high risk for intraventricular hemorrhage and encephalopathy ,9,10,26 and the immature brain seems particularly prone to experience seizures in response to injury. 21 The later onset of seizures in the group of extremely preterm compared to preterm neonates born at an older gestational age could thus be due to the different stage of maturation of the brain, with effects on the means to initiate and sustain electrical discharges. 27 As reported previously by others, 2,3 we confirmed the increased risk of premature mortality or adverse sequelae. Among the perinatal risk factors considered, a 5-minute Apgar score of 0-7 and certain etiologies were significantly associated with mortality. Other factors shown by univariate analysis to predict mortality of NS were not confirmed by our multivariate analysis models. A low 5-minute Apgar score is reported as a predictor of mortality also by the Neurological Collaborative Perinatal Project study data, with only a small difference in outcome between those with 5-minute scores of 0-3 and those with a score of 4-6.
2
In our sample, neonates who died presented with the etiologies (HIE, brain hemorrhages, infections, inborn errors of metabolism, cerebral malformations) described in literature as associated with a poor prognosis, confirming that the underlying cause of NS is a strong predictor of the outcome. 28, 29 The most frequent etiology among term neonates who died was HIE, but considering both term and preterm neonates the cerebral hemorrhage was the most representative etiology. However, cerebral malformations and inborn errors of metabolism presented the highest HR for mortality. In our study, female gender and the occurrence of status epilepticus were associated with epilepsy. The correlation between neonatal status epilepticus and subsequent epilepsy has been already reported 30 and further confirmed by a US study on risk factors for epilepsy in children with neonatal encephalopathy 31 and in a cohort with a prolonged followup. 32 To our knowledge, a relationship among female sex, NS, and postneonatal epilepsy has not been reported so far, 33 and this finding deserves further investigation.
Our study has strengths and limitations. The major strength is the population base. The sample is representative of the general population and, in this regard, reflects the full spectrum of NS. A second strength is the quality of the diagnosis, as all cases had EEG confirmation and all tracings were examined by the same experienced neurophysiologist and reviewed by a second electroencephalographist. A third strength is the accuracy of our screening process because, along with neonates with suspected seizures, we also investigated neonates at high risk of seizures. The major limitation is the small sample. For this reason, our rate is imprecise, as shown by the wide confidence intervals found in subgroups of patients. Another limitation is that we performed routine-length neonatal EEG studies that are suitable to determine if paroxysmal events are seizures but are not sufficient to screen for NS in at-risk neonates. Ideally the latter neonates should be monitored with v-EEG for 24 hours for evaluation of seizures. 19 For the study purposes, only the EEG recordings with the first seizures were considered; however, for clinical purposes, we usually monitored the seizing neonates with repeated v-EEGs the same day and in the following days in order to monitor the background EEG activity, the efficacy of the therapy, the recurrence of seizures, and clinical needs.
In conclusion, NS are a fairly common clinical condition in the general population and are associated with a higher risk of mortality and morbidity in survivors. The incidence of NS is inversely associated with gestational age and weight at birth. There are some perinatal factors that should be carefully considered and further evaluated because they seem to have a prognostic value for mortality and epilepsy in children with NS.
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